.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Evaluating the Current and Future Opportunities for HIV PrEP

Discussion on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force PrEP guidelines and Affordable Care Act Part 47 for payers and providers.

EP. 1: Creating a Successful HIV PrEP Program

December 23rd 2021

Clinician Moti Ramgopal, MD, FACP, FIDSA, highlights key components of a successful HIV PrEP program and comments on the role of providers in introducing these components throughout a patient’s continuum of care to maximize outcomes.

EP. 2: Increasing the Uptake of HIV PrEP in the Community

February 8th 2022

Considerations to help identify and increase utilization of PrEP therapy among patients who are eligible for treatment.

EP. 3: Economic Impact of HIV

February 15th 2022

The financial burden associated with HIV and the potential effects of PrEP uptake on overall costs of care.

EP. 4: Population Health and HIV PrEP

February 15th 2022

Payer perspective regarding strategies that can be deployed to help improve the patient/provider experience and utilization of PrEP therapy as prophylaxis against HIV.

EP. 5: Educating Patients About HIV PrEP

February 22nd 2022

Recommendations when talking with patients about goals of HIV PrEP and ensuring a patient-centered approach to care.

EP. 6: Patient Adherence to HIV PrEP

February 22nd 2022

Discussion regarding HIV PrEP walkaway rates and strategies that can help support patients and increase adherence to therapy.

EP. 7: HIV PrEP and Multidisciplinary Care

March 1st 2022

The advantages of coordinated care between multiple health care providers when managing patients on HIV PrEP therapy.

EP. 8: Addressing Disparities and Increasing Access to HIV PrEP

March 1st 2022

Strategies that can help address disparities in care for patients with HIV and reach high-risk groups of patients to ensure access to screening and PrEP.

EP. 9: Preventive Health Guidelines and Payer Support for HIV PrEP

March 8th 2022

Updates to the US Preventive Services Task Force grade A recommendation for HIV PrEP therapy and payer response to supporting providers and pharmacists who prescribe therapies used as prophylaxis.

EP. 10: Developments in HIV Prophylaxis: New PrEP Options

March 8th 2022

An overview of HIV PrEP therapies in the pipeline and their potential roles as they are introduced into the community for use among high-risk populations.